Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

URGNURGN
5 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in UROGEN PHARMA LTD

Qube Research & Technologies Ltd previously held 0 shares of URGN (UROGEN PHARMA LTD), worth $0 as of 2023-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$122,000

Total Shares Change

-14,943

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q2
Latest
Exited
0
-100.0%
$00.0%$10.74
0
2023-Q1
Increased
46,213
+173.6%
$427,0080.0%$8.38
39
2022-Q4
Increased
16,893
+27.1%
$149,8410.0%$8.87
28
2022-Q3
Decreased
13,289
-11.1%
$111,0000.0%$8.22
0
2022-Q2
New
14,943
-
$122,0000.0%$7.81
31

Other major holders of URGN: RTW INVESTMENTS, LP, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used